NCT03284567 (FFABC) is a NA clinical trial of Football fitness in Breast Neoplasm Female, sponsored by University of Copenhagen.

Who is sponsoring NCT03284567?

NCT03284567 is sponsored by University of Copenhagen.

What drugs are being tested in NCT03284567?

Interventions in NCT03284567: Football fitness.

What condition does NCT03284567 study?

NCT03284567 studies Breast Neoplasm Female.

Is NCT03284567 still recruiting?

NCT03284567 is currently completed. Last updated 1 October 2021.

Last reviewed 2021-10-01 · How we verify

NCT03284567: FFABC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Football Fitness After Breast Cancer

Completed NA Last updated 1 October 2021

What this trial tests

NA trial testing Football fitness in Breast Neoplasm Female in 69 participants. Completed in 20 January 2020.

Timeline

20 March 2017

Primary endpoint
30 November 2019

20 January 2020

Quick facts

Lead sponsor	University of Copenhagen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	69
Start date	20 March 2017
Primary completion	30 November 2019
Estimated completion	20 January 2020
Sites	1 location across Denmark

Drugs / interventions tested

Football fitness

Conditions studied

Breast Neoplasm Female — all drugs for Breast Neoplasm Female →

Sponsor

University of Copenhagen

Who can join

Adults 18 to 75, female only, with Breast Neoplasm Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Late effects of breast cancer treatment are widely reported including deteriorating fitness, fatigue, loss of muscle and bone mass, and increased body fat percentage. Exercise interventions may ameliorate a number of these effects including fatigue, fitness and improve quality of life. However only limited knowledge exists on the potential of novel interventions and settings, such as sports outside the hospital setting, to improve late effects of breast cancer treatment. The 'Football Fitness After Breast Cancer' (FF ABC) study is a randomized trial comparing the effects of a football training intervention with standard treatment approaches on fitness, bone mineralization, body composition, muscle strength, blood pressure, and patient-reported outcomes in women treated for breast cancer.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Exercise intensity and cardiovascular health outcomes after 12 months of football fitness training in women treated for stage I-III breast cancer: Results from the football fitness After Breast Cancer (ABC) randomized controlled trial.
Uth J, Fristrup B, Sørensen V, Helge EW, et al · · 2020 · cited 19× · PMID 32800792 · DOI 10.1016/j.pcad.2020.08.002
Effects of football fitness training on lymphedema and upper-extremity function in women after treatment for breast cancer: a randomized trial.
Bloomquist K, Krustrup P, Fristrup B, Sørensen V, et al · · 2021 · cited 10× · PMID 33423594 · DOI 10.1080/0284186x.2020.1868570

Verify or expand the search:

Other recruiting trials for Breast Neoplasm Female

Currently open trials in the same condition.

NCT07465523 — A Novel Approach in the Evaluation of Breast Masses With Doppler US · recruiting
NCT06711523 — Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy · Phase 3 · active not recruiting
NCT05277935 — Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib · NA · recruiting
NCT06234137 — A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrot · NA · recruiting
NCT04812652 — Digitally Distributed Yoga for Women Treated for Breast Cancer · NA · active not recruiting

Other University of Copenhagen trials

Trials by the same sponsor.

NCT07461324 — Surgeons' Prediction of Dental Surgery Complications and the Influence of Patient Characteristics: Development of an AI · not yet recruiting
NCT07389421 — School Meals in Denmark · NA · not yet recruiting
NCT07450690 — Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy · NA · recruiting
NCT07302880 — The Acute Interference of Biotin in Blood Analysis · NA · not yet recruiting
NCT07312981 — The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03284567 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Copenhagen
Last refreshed: 1 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03284567.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing